Suppression subtractive hybridization reveals differentially expressed genes in supraspinous ligaments of patients with ankylosing spondylitis

Zhang,Ying; Hu,Xu; Zhang,Chao; Zhou,Yue; Chu,Tong‑Wei

doi:10.3892/mmr.2015.3272

Suppression subtractive hybridization reveals differentially expressed genes in supraspinous ligaments of patients with ankylosing spondylitis

Authors:
- Ying Zhang
- Xu Hu
- Chao Zhang
- Yue Zhou
- Tong‑Wei Chu
View Affiliations

Affiliations: Department of Orthopedics, Xinqiao Hospital, The Third Military Medical University, Chongqing 400037, P.R. China
Published online on: January 29, 2015 https://doi.org/10.3892/mmr.2015.3272
Pages: 4482-4488

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ankylosing spondylitis (AS) is a severe chronic inflammatory disease that may ultimately result in the development of a 'bamboo‑like' spine. Although the pathological changes that occur in AS have been extensively investigated, the mechanism underlying spinal fusion during AS remains elusive. Differentially expressed genes (DEGs) in paraspinal tissues from patients with AS compared with those from healthy controls were therefore investigated. Polymerase chain reaction (PCR)‑based suppression subtractive hybridization was performed using total mRNA from the supraspinal ligaments of three patients with AS and three patients with spinal fractures as controls. From this, 27 genes were identified in all of the three independent forward libraries, which were defined as DEGs associated with AS. Reverse transcription‑quantitative PCR demonstrated that six DEGs were overexpressed in the tissues from patients with AS compared with those from individuals in the control group, including those encoding transforming growth factor β types I and III receptor, vascular endothelial growth factor, matrix metalloproteinase‑3, core‑binding factor α1 and bone morphogenetic protein 2. Western blot analysis showed increased expression in all six of these proteins in the samples from patients with AS compared with those in the control groups. These findings suggested that changes in the expression of these genes and proteins are associated with the development of spinal fusion during the pathogenesis of AS. Furthermore, these genes may be novel markers of the risk of developing AS, in addition to being targets for the treatment of this disease.

View Figures

View References

1	Appel H, Kuhne M, Spiekermann S, et al: Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: evaluation of the bone-cartilage interface and subchondral bone marrow. Arthritis Rheum. 54:1805–1813. 2006. View Article : Google Scholar : PubMed/NCBI
2	Chou CH, Lin MC, Peng CL, et al: A nationwide population-based retrospective cohort study: increased risk of acute coronary syndrome in patients with ankylosing spondylitis. Scand J Rheumatol. 43:132–136. 2014. View Article : Google Scholar
3	Braun J and Sieper J: Ankylosing spondylitis. Lancet. 369:1379–1390. 2007. View Article : Google Scholar : PubMed/NCBI
4	Thomas GP and Brown MA: Genomics of ankylosing spondylitis. Discov Med. 10:263–271. 2010.PubMed/NCBI
5	Lories RJ and Baeten DL: Differences in pathophysiology between rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol. 27(Suppl 55): S10–S14. 2009.
6	Tam LS, Gu J and Yu D: Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol. 6:399–405. 2010. View Article : Google Scholar : PubMed/NCBI
7	Khan MA, Mathieu A, Sorrentino R and Akkoc N: The pathogenetic role of HLA-B27 and its subtypes. Autoimmun Rev. 6:183–189. 2007. View Article : Google Scholar : PubMed/NCBI
8	Wei JC, Tsai WC, Lin HS, Tsai CY and Chou CT: HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients. Rheumatology (Oxford). 43:839–842. 2004. View Article : Google Scholar
9	Diaz-Peña R, Blanco-Gelaz MA, Suárez-Alvarez B, et al: Activating KIR genes are associated with ankylosing spondylitis in Asian populations. Hum Immunol. 69:437–442. 2008. View Article : Google Scholar : PubMed/NCBI
10	Kim TH, Stone MA, Rahman P, et al: Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and Korea. J Rheumatol. 32:1907–1910. 2005.PubMed/NCBI
11	McGarry F, Neilly J, Anderson N, Sturrock R and Field M: A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. Rheumatology (Oxford). 40:1359–1364. 2001. View Article : Google Scholar
12	van Sijl AM, van Eijk IC, Peters MJ, et al: Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis. Ann Rheum Dis. 2013.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
13	Feldtkeller E and Braun J: Impact of sex on inheritance of ankylosing spondylitis. Lancet. 355:1096–1097; author reply 1098. 2000. View Article : Google Scholar : PubMed/NCBI
14	Davey-Ranasinghe N and Deodhar A: Osteoporosis and vertebral fractures in ankylosing spondylitis. Curr Opin Rheumatol. 25:509–516. 2013. View Article : Google Scholar : PubMed/NCBI
15	Xu HF, Zhang L, Zhang Y and Chu TW: Histopathologicai and ultra-structural observation of the supraspinal ligaments in ankylosing spondylitis. Chinese Journal of Rheumatology. 17:152–154. 2013.In Chinese.
16	Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315–324. 1988. View Article : Google Scholar : PubMed/NCBI
17	Appel H, Loddenkemper C, Grozdanovic Z, et al: Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther. 8:R1432006. View Article : Google Scholar : PubMed/NCBI
18	Pan X, Yue J, Ding G, et al: Leucine-rich repeat 11 of Toll-like receptor 9 can tightly bind to CpG-containing oligodeoxy-nucleotides, and the positively charged residues are critical for the high affinity. J Biol Chem. 287:30596–30609. 2012. View Article : Google Scholar : PubMed/NCBI
19	Stone MA, Inman RD, Wright JG and Maetzel A: Validation exercise of the Ankylosing Spondylitis Assessment Study (ASAS) group response criteria in ankylosing spondylitis patients treated with biologics. Arthritis Rheum. 51:316–320. 2004. View Article : Google Scholar : PubMed/NCBI
20	Hreggvidsdottir HS, Noordenbos T and Baeten DL: Inflammatory pathways in spondyloarthritis. Molecular immunology. 57:28–37. 2014. View Article : Google Scholar
21	Gratacós J, Collado A, Filella X, et al: Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol. 33:927–931. 1994. View Article : Google Scholar : PubMed/NCBI
22	Stone MA and Inman RD: The genetics of cytokines in ankylosing spondylitis. J Rheumatol. 28:1203–1206. 2001.PubMed/NCBI
23	Massagué J, Blain SW and Lo RS: TGFbeta signaling in growth control, cancer, and heritable disorders. Cell. 103:295–309. 2000. View Article : Google Scholar : PubMed/NCBI
24	Derynck R, Akhurst RJ and Balmain A: TGF-beta signaling in tumor suppression and cancer progression. Nat Genet. 29:117–129. 2001. View Article : Google Scholar : PubMed/NCBI
25	Blobe GC, Schiemann WP, Pepin MC, et al: Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling. J Biol Chem. 276:24627–24637. 2001. View Article : Google Scholar : PubMed/NCBI
26	Kirkbride KC, Townsend TA, Bruinsma MW, Barnett JV and Blobe GC: Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor. J Biol Chem. 283:7628–7637. 2008. View Article : Google Scholar : PubMed/NCBI
27	Ducy P, Starbuck M, Priemel M, et al: A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 13:1025–1036. 1999. View Article : Google Scholar : PubMed/NCBI
28	Otto F, Thornell AP, Crompton T, et al: Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 89:765–771. 1997. View Article : Google Scholar : PubMed/NCBI
29	Portal-Núñez S, Lozano D and Esbrit P: Role of angiogenesis on bone formation. Histol Histopathol. 27:559–566. 2012.PubMed/NCBI
30	Clarkin CE and Gerstenfeld LC: VEGF and bone cell signalling: an essential vessel for communication? Cell Biochem Funct. 31:1–11. 2013. View Article : Google Scholar
31	Maksymowych WP: Biomarkers in spondyloarthritis. Curr Rheumatol Rep. 12:318–324. 2010. View Article : Google Scholar : PubMed/NCBI
32	Soliman E, Labib W, el-Tantawi G, Hamimy A, Alhadidy A and Aldawoudy A: Role of matrix metalloproteinase-3 (MMP-3) and magnetic resonance imaging of sacroiliitis in assessing disease activity in ankylosing spondylitis. Rheumatol Int. 32:1711–1720. 2012. View Article : Google Scholar
33	Arends S, van der Veer E, Groen H, et al: Serum MMP-3 level as a biomarker for monitoring and predicting response to etanercept treatment in ankylosing spondylitis. J Rheumatol. 38:1644–1650. 2011. View Article : Google Scholar : PubMed/NCBI